DE3775335D1 - Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe. - Google Patents

Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe.

Info

Publication number
DE3775335D1
DE3775335D1 DE8787201845T DE3775335T DE3775335D1 DE 3775335 D1 DE3775335 D1 DE 3775335D1 DE 8787201845 T DE8787201845 T DE 8787201845T DE 3775335 T DE3775335 T DE 3775335T DE 3775335 D1 DE3775335 D1 DE 3775335D1
Authority
DE
Germany
Prior art keywords
rhine
peroral
derivatives
delayed release
galenic formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787201845T
Other languages
English (en)
Inventor
Vanna Springolo
Germano Coppi
Mario Ercole Scevola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Medidom SA
Original Assignee
Proter SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proter SpA filed Critical Proter SpA
Application granted granted Critical
Publication of DE3775335D1 publication Critical patent/DE3775335D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE8787201845T 1986-10-01 1987-09-25 Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe. Expired - Fee Related DE3775335D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21867/86A IT1197316B (it) 1986-10-01 1986-10-01 Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico

Publications (1)

Publication Number Publication Date
DE3775335D1 true DE3775335D1 (de) 1992-01-30

Family

ID=11187979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787201845T Expired - Fee Related DE3775335D1 (de) 1986-10-01 1987-09-25 Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe.

Country Status (5)

Country Link
US (1) US4861599A (de)
EP (1) EP0264989B1 (de)
JP (1) JP2572781B2 (de)
DE (1) DE3775335D1 (de)
IT (1) IT1197316B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
IT1282381B1 (it) * 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
AR026801A1 (es) * 2000-01-12 2003-02-26 Medidom Lab Sustancias para uso en el tratamiento de la psoriasis
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US8821924B2 (en) 2007-09-14 2014-09-02 Wockhardt Ltd. Rhein or diacerein compositions
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
CA2709236A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
WO2009133431A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Oral liquid compositions of rhein or diacerein
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
MX336355B (es) 2009-03-04 2016-01-14 Orexo Ab Formulacion resistente al abuso.
DK2427177T3 (en) 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
NZ608598A (en) 2010-09-07 2015-03-27 Orexo Ab A transdermal drug administration device
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
IT8621867A1 (it) 1988-04-01
JPS63146816A (ja) 1988-06-18
EP0264989A1 (de) 1988-04-27
JP2572781B2 (ja) 1997-01-16
US4861599A (en) 1989-08-29
IT8621867A0 (it) 1986-10-01
IT1197316B (it) 1988-11-30
EP0264989B1 (de) 1991-12-18

Similar Documents

Publication Publication Date Title
DK619987A (da) Galenisk formulering
ES2015061B3 (es) Ingrediente antiespuma.
DE3778106D1 (de) Dosierungsform mit verzoegernder freisetzung.
DE3775335D1 (de) Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe.
DE3788385T2 (de) Pyrimidin-Derivate.
NO872961D0 (no) Pyrimidinderivater.
DE3777997D1 (de) Piperidinderivate.
DE3782439T2 (de) Dihydropyridin-formulierung mit verzoegerter freigabe.
DE3761308D1 (de) 18-phenylestrane-derivate.
FI872634A (fi) Antihypertensiva dihydropyridinderivat.
DE3786834D1 (de) 5-fluoro-uracil-derivate.
NO872959D0 (no) Pyrimidinderivater.
NO873362L (no) Pyrimidinderivater.
FI864526A0 (fi) Foerfarande foer tillvaratagande av vaerme i samband med en gasturbinprocess.
DE3778624D1 (de) Glucosylmoranoline-derivate.
DE3780338D1 (de) Indenopyrimidin-derivate.
DE3781831D1 (de) Aralkylimidazolderivate.
FI875510A (fi) Virusdoedande komposition.
DE3774759D1 (de) Alkenamid-derivate.
DE3785480D1 (de) Macrolid-derivate.
DE3766425D1 (de) Triazinderivate von piperidinylamidinen.
DE68906449D1 (de) Herstellung von 2,6-dioxopiperidinderivate.
DE3769757D1 (de) Hydrofluoren-derivate.
DE68905866D1 (de) Anilinopyrimidin-derivate.
ATE81973T1 (de) Dihydropyridin-formulierung mit verzoegerter freigabe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRE MEDIDOM S.A., GENEVE, CH

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee